A Novel Hydrogen Sulfide Prodrug, <scp>SG</scp>1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients
Summary Recent studies demonstrate robust molecular cross talk and signaling between hydrogen sulfide (H 2 S) and nitric oxide ( NO ). Heart failure ( HF ) patients are deficient in both H 2 S and NO , two molecules that are critical for cardiovascular homeostasis. A phase I clinical trial of a nove...
Salvato in:
Autori principali: | , , , , , |
---|---|
Natura: | Artigo |
Lingua: | inglese |
Pubblicazione: |
2015
|
Accesso online: | https://doi.org/10.1111/1755-5922.12128 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1755-5922.12128 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|